Palo Protocol — Nasal
SS-31 25 mg Nasal — Palo Protocol — coming soon

Palo Protocol: Nasal

SS-31 25 mg Nasal

Longevity

25 mg in 10 ml · 15 ml bottle

SS-31 is elamipretide — a compound in real clinical development with real human data. That is exactly why it belongs in a regulated channel and not in a shopping cart.

Not available for purchase

What we know

Mechanism
A mitochondria-targeting tetrapeptide that binds cardiolipin on the inner mitochondrial membrane, studied for effects on electron transport efficiency.
Evidence state
Developed as elamipretide and taken through multiple human trials, including in primary mitochondrial myopathy.
Regulatory note
An investigational drug under active clinical development. Selling it outside a trial or prescriber pathway is not lawful.

Disclaimer

This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.